SOLVETX
Live / Applied — Statement of use — processing complete, to examiner (as of 14 Feb 2026)
What this means for you
Not registered yet, but its 26 Jan 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97240145
- Mark type
- Stylized text
- Filed
- 26 Jan 2022
- Published for opposition
- 20 Dec 2022
- Attorney of record
- Carla B. Oakley
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and biological preparations for the treatment of immune system related and oncological diseases and disorders, and treatment of hematologic and solid tumor cancers; diagnostic preparations for medical use, namely, biological diagnostic preparations for medical use
Owner
- Solve Therapeutics, Inc., San Diego, CA, US
- Solve Therapeutics, Inc., San Diego, CA, US
Prosecution history
- 14 Feb 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 13 Feb 2026 — USE AMENDMENT FILED
- 13 Feb 2026 — TEAS STATEMENT OF USE RECEIVED
- 23 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Dec 2025 — SOU EXTENSION 5 GRANTED
- 05 Aug 2025 — SOU EXTENSION 5 FILED
- 22 Dec 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 06 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 06 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Feb 2025 — SOU EXTENSION 4 GRANTED
- 06 Feb 2025 — SOU EXTENSION 4 FILED
- 05 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 13 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Aug 2024 — SOU EXTENSION 3 GRANTED
- 14 Aug 2024 — SOU EXTENSION 3 FILED